Search contract descriptions, companies and agencies.
PRE-CLINICAL MODELS OF INFECTIOUS DISEASES: ESTABLISHMENT OF SMALL ANIMAL MODELS FOR SCREENING MCMS FOR THE 2019 NOVEL CORONAVIRUS (SARS-COV-2)
Total Committed
$1.3M
Product or Service Description
Biomedical R&D
Contracting Agency
Effective Date
March 29, 2021
Funding Department
NATIONAL INSTITUTES OF HEALTH NIAID
Type
Firm fixed price
Solicitation Procedure
Subject to multiple award fair opportunity
Extent Competed
Full and open competition
Recent Contract Actions 
Contracts can have multiple “contract actions”: This is how agencies spend money for a specific purpose, adjust the amount committed or change the contract in a way that doesn’t affect the amount. That last scenario is usually indicated by a $0 action. If there is a contract action for a negative amount, it generally means the contract was adjusted or canceled.
| Vendor | Description | Signed | Reason for Change | Amount Committed |
|---|---|---|---|---|
| UTAH STATE UNIVERSITY | PERFORM HIGH THROUGHPUT IN VIVO EFFICACY TESTING OF THERAPEUTIC CANDIDATES AGAINST SARS-COV-2 | March 29, 2021 | $379,235 | |
| UTAH STATE UNIVERSITY | PRE-CLINICAL MODELS OF INFECTIOUS DISEASES: ESTABLISHMENT OF SMALL ANIMAL MODELS FOR SCREENING MCMS FOR THE 2019 NOVEL CORONAVIRUS (SARS-COV-2) | March 23, 2020 | $921,951 |
About this data
This data comes from the Federal Procurement Data System, which includes all contracts worth $10,000 or more. We look at all contracts that are tagged with the procurement code for COVID-19 or otherwise started in 2020 and contain “COVID-19” in the description. Department of Defense contracting data is subject to a 90-day delay before it appears in the data.